After Appalachian hospitals merged into a monopoly, their ERs slowed to a crawl

FHS
March 25, 2024
11:18 am

In the small Appalachian city of Bristol, Virginia, City Council member Neal Osborne left a meeting on the morning of Jan. 3 and rushed himself to the hospital.

MaxCyte and Kamau Therapeutics sign platform license agreement

Kamau’s lead investigational programme, nula-cel, which is based on HDR editing, is currently in clinical development for sickle cell disease. Credit: Babul Hosen /Shutterstock. MaxCyte,

September 17, 2024

Genentech is shedding even more employees

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. We await

August 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

After Appalachian hospitals merged into a monopoly, their ERs slowed to a crawl

MaxCyte and Kamau Therapeutics sign platform license agreement

State Parties to the International Health Regulations take major step towards agreeing on the package of amendments

Genentech is shedding even more employees

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe